Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Sep 16, 2025; 17(9): 111734
Published online Sep 16, 2025. doi: 10.4253/wjge.v17.i9.111734
Published online Sep 16, 2025. doi: 10.4253/wjge.v17.i9.111734
Efficacy and safety of pretraction-assisted endoscopic submucosal dissection for treating rectal neuroendocrine tumors
Xiao-Xiong Guo, Si-Han Zhang, Ai-Jin Chen, Yan-Ling Chen, Feng-Lin Chen, Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China
Author contributions: Guo XX performed the data analysis and drafted the manuscript; Zhang SH, Chen AJ, Chen YL contributed to data collection; Chen FL conceived and designed the study, and critically revised the manuscript; All authors have read and approved the final version to be published.
Supported by Fujian Province National Key Clinical Specialty Construction Project (Minwei Medical Policy Letter), No. [2023]1594.
Institutional review board statement: This study was approved by the Ethics Committee of Fujian Medical University Union Hospital (2025KY287).
Informed consent statement: Informed consent was waived for this retrospective study with the approval of the institutional ethical review committee, as the research involved no direct human interaction and utilized patient data obtained following written consent for clinical treatment. All identifiable patient information was removed during data processing to ensure full confidentiality and privacy protection.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: No additional data are available.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Feng-Lin Chen, MD, Department of Gastroenterology, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, Fujian Province, China.
Received: July 8, 2025
Revised: August 2, 2025
Accepted: August 20, 2025
Published online: September 16, 2025
Processing time: 66 Days and 11.3 Hours
Revised: August 2, 2025
Accepted: August 20, 2025
Published online: September 16, 2025
Processing time: 66 Days and 11.3 Hours
Core Tip
Core Tip: This study compares pretraction-assisted endoscopic submucosal dissection (p-ESD) with conventional endoscopic submucosal dissection for rectal neuroendocrine tumors ≤ 15 mm. The results show that p-ESD significantly shortens dissection time, improves R0 resection rates, and reduces intraoperative bleeding and muscularis propria injury. These findings suggest that p-ESD is a safe, efficient, and technically advantageous technique for treating rectal neuroendocrine tumors.